Gwen P. Tatsuno

Glycoform and Net Charge Heterogeneity in gp120 Immunogens Used in HIV Vaccine Trials

Bin Yu, Javier F. Morales, Sara M. O’Rourke et al. · PLoS ONE · 2012 · 31 citations · Full text

Sequences in Glycoprotein gp41, the CD4 Binding Site, and the V2 Domain Regulate Sensitivity and Resistance of HIV-1 to Broadly Neutralizing Antibodies

Sara M. O’Rourke, Becky Schweighardt, Pham Phung et al. · Journal of Virology · 2012 · 28 citations · Full text

Immunology, Glycoprotein Gp41, Molecular Biology +16

HIV-1 Envelope Proteins and V1/V2 Domain Scaffolds with Mannose-5 to Improve the Magnitude and Quality of Protective Antibody Responses to HIV-1

Javier F. Morales, Trevor J. Morin, Bin Yu et al. · Journal of Biological Chemistry · 2014 · 23 citations · Full text

Immunology, Molecular Biology, Immunodominance +22

Robotic selection for the rapid development of stable CHO cell lines for HIV vaccine production

Sara M. O’Rourke, Gabriel Byrne, Gwen P. Tatsuno et al. · PLoS ONE · 2018 · 20 citations · Full text

Engineering, Hiv Vaccines, Immunology +21

Glycan modifications to the gp120 immunogens used in the RV144 vaccine trial improve binding to broadly neutralizing antibodies

Rachel C. Doran, Gwen P. Tatsuno, Sara M. O’Rourke et al. · PLoS ONE · 2018 · 18 citations · Full text

Neutralizing Antibodies, Immunology, Immunodominance +20